01 Jun 2023
Monitoring pharmaceutical expenditure
Biosimilar medicines in Italy: AIFA reports updated
The analyses of consumption and expenditure trends and regional variability are online.
31 May 2023
Innovative medicinal products
Innovative medicines list: AIFA publishes May 2023 update
AIFA updates the list of medicines that, in the opinion of the Scientific and Technical Committee (CTS), meet the requirement of full or conditional therapeutic innovativeness.
30 May 2023
Hepatitis C: update of 29 May 2023 concerning enrolled patients
AIFA has published the updated weekly data concerning treatments with new second-generation direct acting antiviral agents (DAAs) for chronic hepatitis C, as collected by AIFA Monitoring registries.
24 May 2023
AIFA Board of Directors requests further information on the reimbursement of contraceptive pills
The AIFA Board of Directors has noted that the Agency's Advisory Committees have not yet developed precise indications on the age groups to be granted the birth control pill free of charge, the distribution methods, and the costs for the National Health System in the various reimbursement cases.
05 Jun 2023
Innovation and planning
Enabling oncology scientists' participation in medicine regulation (pilot project) (new)
12 May 2023
Safety of medicinal products
Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects
Vai alla sezione COVID-19
Banca dati dei farmaci content
Questions regarding drug efficacy, safety and availability
Hero AIFA con links homepage
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
07 - 09
19 - 21